Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lund

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
European Journal of Pharmacology|June 19, 2008
Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonistFabrice Piu, Cindy Cheevers, Lene Hyldtoft, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 12, 2021
In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune ResponseWorapol Ngamcherdtrakul, Moataz Reda, Molly A Nelson, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
A targetable developmental program co-regulates angiogenesis and immune evasionPietro Berico, Amanda Flores Flores Yanke, Fatemeh Vand Rajabpour, et al.
Science Translational Medicine|September 15, 2017
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanomaManuel Fankhauser, Maria A S Broggi, Lambert Potin, et al.
Frontiers in Immunology|February 16, 2024
Quantitative multiplex immunohistochemistry reveals inter-patient lymphovascular and immune heterogeneity in primary cutaneous melanomaJulia Femel, Cameron Hill, Irineu Illa Bochaca, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responsesInna Serganova, Giorgia Colombo, Francesco Ballesio, et al.
The Lancet. Diabetes & Endocrinology|May 22, 2026
Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trialMads M Helsted, Christiane Fonnesbech-Wulff, Nina L Schaltz, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanomaTriantafyllia Karakousi, Vanessa Cristaldi, Maria Luiza Lopes de Oliveira, et al.
Journal for Immunotherapy of Cancer|December 3, 2020
SITC cancer immunotherapy resource document: a compass in the land of biomarker discoverySiwen Hu-Lieskovan, Srabani Bhaumik, Kavita Dhodapkar, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Lymphatic constraint of germinal centers optimizes protective antibody responsesTenny Mudianto, Gabrielle R Berman, Kimberly Zaldana, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
European Journal of Pharmacology|June 19, 2008
Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonistFabrice Piu, Cindy Cheevers, Lene Hyldtoft, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 12, 2021
In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune ResponseWorapol Ngamcherdtrakul, Moataz Reda, Molly A Nelson, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
A targetable developmental program co-regulates angiogenesis and immune evasionPietro Berico, Amanda Flores Flores Yanke, Fatemeh Vand Rajabpour, et al.
Science Translational Medicine|September 15, 2017
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanomaManuel Fankhauser, Maria A S Broggi, Lambert Potin, et al.
Frontiers in Immunology|February 16, 2024
Quantitative multiplex immunohistochemistry reveals inter-patient lymphovascular and immune heterogeneity in primary cutaneous melanomaJulia Femel, Cameron Hill, Irineu Illa Bochaca, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responsesInna Serganova, Giorgia Colombo, Francesco Ballesio, et al.
The Lancet. Diabetes & Endocrinology|May 22, 2026
Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trialMads M Helsted, Christiane Fonnesbech-Wulff, Nina L Schaltz, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanomaTriantafyllia Karakousi, Vanessa Cristaldi, Maria Luiza Lopes de Oliveira, et al.
Journal for Immunotherapy of Cancer|December 3, 2020
SITC cancer immunotherapy resource document: a compass in the land of biomarker discoverySiwen Hu-Lieskovan, Srabani Bhaumik, Kavita Dhodapkar, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Lymphatic constraint of germinal centers optimizes protective antibody responsesTenny Mudianto, Gabrielle R Berman, Kimberly Zaldana, et al.
Pageof 19